Insight Molecular Diagnostics Inc.
Organization details
- Legal name
- Insight Molecular Diagnostics Inc.
- Former names
- OncoCyte Corp
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2835 — In Vitro & In Vivo Diagnostic Substances
- Jurisdiction of incorporation
- California
- Headquarters city
- Nashville
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- IMDX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001642380
- EIN
- 27-1041563
Board of directors
-
Alfred D. Kingsley · DirectorSince 2023
-
Andrew Arno · DirectorSince 2023
-
Andrew J. Last · DirectorSince 2023
-
John Peter Gutfreund · DirectorSince 2023
-
Josh Riggs · Director · CEO and PresidentSince 2023
-
Lou Silverman · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 11, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.3%
-
99.9%
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 5 other boards. 3 are in the same sector.
- via Andrew Arno
-
Catheter Precision Inc. Same sectorvia Andrew Arno
-
Lineage Cell Therapeutics Inc. Same sectorvia Alfred D. Kingsley
-
STAAR Surgical Company Same sectorvia Lou Silverman
- via Andrew Arno
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $5,685,120
- 14 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2026 | Andrew Arno Director | Shares withheld for tax | −12,100 | $5.69 | $68,849 |
| Jul 1, 2026 | Andrew J. Last Director | Shares withheld for tax | −7,700 | $5.69 | $43,813 |
| Jul 1, 2026 | Lou Silverman Director | Shares withheld for tax | −7,700 | $5.69 | $43,813 |
| Jun 11, 2026 | Lou Silverman Director | Grant or award | +26,943 | — | — |
| Jun 11, 2026 | Andrew J. Last Director | Grant or award | +26,943 | — | — |
| Jun 11, 2026 | Andrew Arno Director | Grant or award | +32,331 | — | — |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +250,923 | $3.64 | $913,360 |
| Apr 27, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +0 | — | — |
| Apr 24, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +38,880 | $3.53 | $137,246 |
| Apr 24, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +0 | — | — |
| Apr 23, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +280,381 | $3.50 | $981,334 |
| Apr 23, 2026 | BROADWOOD PARTNERS, L.P. 10% owner | Open-market purchase | +0 | — | — |
| Apr 20, 2026 | BROADWOOD CAPITAL INC 10% owner | Open-market purchase | +40,690 | $3.88 | $157,877 |
| Apr 20, 2026 | BROADWOOD CAPITAL INC 10% owner | Open-market purchase | +0 | — | — |
| Apr 17, 2026 | BROADWOOD CAPITAL INC 10% owner | Open-market purchase | +40,114 | $3.57 | $143,207 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Insight Molecular Diagnostics Inc.
Who is the CEO of Insight Molecular Diagnostics Inc.?
Josh Riggs is Insight Molecular Diagnostics Inc.'s CEO and President.
How many directors are on Insight Molecular Diagnostics Inc.'s board?
Insight Molecular Diagnostics Inc.'s board has 6 directors: Alfred D. Kingsley, Andrew Arno, Andrew J. Last, John Peter Gutfreund, Josh Riggs and Lou Silverman.
Are Insight Molecular Diagnostics Inc. insiders buying or selling shares?
Over the last 12 months, Insight Molecular Diagnostics Inc. insiders bought $5.7 million of shares in 14 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="insight-molecular-diagnostics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.